论文部分内容阅读
As an epidermal growth factor receptor(EGFR)tyrosine kinase lung cancer-targeted drug,gefitinib has been widely applied in the treatment of non-small cell lung cancer(NSCLC).The present clinical application has shown that EGFR genovariation might cause th